1.Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease/ [& T; m$ `( Q# g2 i1 W
2.In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.
发表于 2011-12-14 15:08
